Newest Coronavirus Information
THURSDAY, March 24, 2022 (HealthDay Information)
George Washington College researchers analyzed knowledge on greater than 112,000 sufferers hospitalized with average COVID-19 at 64 well being techniques in the US from Jan. 1, 2020, by way of Sept. 10, 2021.
In comparison with sufferers who weren’t given aspirin, those that acquired aspirin inside the first day of hospitalization had a 1.6% decrease threat of dying, and likewise had a decrease threat of blood clots.
Aged sufferers and people with different well being circumstances appeared to particularly profit from early aspirin remedy, based on the examine, revealed March 24 within the journal JAMA Network Open.
“That is our third examine and the end result of 15 months of labor aspirin use in hospitalized COVID-19 sufferers,” mentioned lead researcher Dr. Jonathan Chow, an affiliate professor on the college’s Faculty of Drugs.
“We proceed to seek out that aspirin use is related to improved outcomes and decrease charges of dying in hospitalized sufferers,” Chow mentioned in a college information launch. “What’s extra, it is low-cost and available, which is necessary in elements of the world the place dearer therapeutics may not be as accessible.”
The group’s first study was revealed in April 2021, whereas the second was revealed in November 2021.
“This analysis is significant to offering physicians and sufferers efficient and accessible COVID-19 therapies to assist scale back in-hospital mortality charges and assist folks recuperate from this probably devastating illness,” mentioned co-author Keith Crandall, director of the college’s Computational Biology Institute.
Copyright © 2021 HealthDay. All rights reserved.
George Washington College, information launch, March 24, 2022